more

FMC (FMC)

(Delayed Data from NYSE)

$58.46 USD

+0.66 (1.14%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $58.43 -0.03 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum D VGM

Industry Rank:

Top 38% (95 out of 252)

Industry: Chemical - Diversified

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

FMC's Fluindapyr Fungicide Secures Registration in Brazil

by Zacks Equity Research Published on August 23,2023

FMC's fluindapyr fungicide gains approval in Brazil. It offers broad-spectrum disease control for row crops.

basic-materials

FMC (FMC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

by Zacks Equity Research Published on August 04,2023

Although the revenue and EPS for FMC (FMC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

FMCPositive Net Change

FMC's Q2 Earnings and Sales Fall Short of Expectations

by Zacks Equity Research Published on August 03,2023

FMC lags second-quarter estimates due to lower volumes as a result of active inventory management by farmers.

FMC (FMC) Lags Q2 Earnings and Revenue Estimates

by Zacks Equity Research Published on August 02,2023

FMC (FMC) delivered earnings and revenue surprises of -15.25% and 0.45%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

FMC Gears Up to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research Published on July 31,2023

FMC's second-quarter performance is likely to have been impacted by channel partners' inventory reduction.

basic-materials

Earnings Preview: FMC (FMC) Q2 Earnings Expected to Decline

by Zacks Equity Research Published on July 26,2023

FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FMCPositive Net Change

FMC Shares Fall on Guidance Cut, Lower Volumes to Hurt Q2

by Zacks Equity Research Published on July 11,2023

FMC revises its second-quarter and full-year 2023 outlook due to unprecedented volume declines caused by inventory reduction.

basic-materials

FMC (FMC) Down 10.5% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research Published on May 31,2023

FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

FMCPositive Net Change

FMC Partners Syngenta to Transform Rice Weed Control in Asia

by Zacks Equity Research Published on May 19,2023

FMC will register and offer tetflupyrolimet as well as a variety of tetflupyrolimet formulations for rice throughout Asia.

basic-materials

FMC Corp's (FMC) Earnings Top Estimates in Q1, Sales Lag

by Zacks Equity Research Published on May 02,2023

FMC Corp (FMC) benefits from strong pricing actions, growth of new products, expanded market access and cost discipline in Q1.

FMC (FMC) Beats Q1 Earnings Estimates

by Zacks Equity Research Published on May 01,2023

FMC (FMC) delivered earnings and revenue surprises of 2.31% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Linde's (LIN) Q1 Earnings Beat Estimates on Higher Prices

by Zacks Equity Research Published on April 27,2023

Increased prices and volumes across beverage and manufacturing and food end markets aid Linde's (LIN) Q1 earnings.

oil-energy

Albemarle (ALB) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research Published on April 26,2023

Albemarle (ALB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Newmont (NEM) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research Published on April 25,2023

Newmont's (NEM) first-quarter results are expected to reflect improved grades across a number of mines, improved gold prices and lower unit costs.

basic-materials